PROM1 and cancer: The potential therapeutic efficiency of PBI-05204 is also suggested by its ability to counteract the growth of the cancer stem cell (CSC) subpopulation, as suggested by the assays based on the formation of CSCs-like enriched tumorspheres and the reduction in the expression of the stem cell marker CD133.